AEON Biopharma, Inc. - Class A Common Stock (AEON)

37 filings reported holding AEON - AEON Biopharma, Inc. - Class A Common Stock as of Q3 2024.
AEON Biopharma, Inc. - Class A Common Stock (AEON) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.57M shares of 39.7M outstanding shares and own 24.09% of the company stock.
Largest 10 shareholders include Polar Asset Management Partners Inc. (3.6M shares), Blue Owl Capital Holdings LP (3.34M shares), VANGUARD GROUP INC (751K shares), Formidable Asset Management, LLC (390K shares), BlackRock, Inc. (265K shares), Ikarian Capital, LLC (258K shares), GEODE CAPITAL MANAGEMENT, LLC (243K shares), BANK OF AMERICA CORP /DE/ (167K shares), TWO SIGMA INVESTMENTS, LP (65.2K shares), and Caprock Group, LLC (62.7K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.